Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
109last 24h
3128last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
Barrons.com158d agoneutral
Getting Alzheimer’s Drugs Into the Brain Is Hard. Now There’s a New Trick.Simply Wall St.159d agoneutral
Biogen Ends BIIB122 Parkinsons Trial And Refocuses Neurodegeneration PipelineSimply Wall St.159d agoneutral
Is COMPASS Pathways (CMPS) Quietly Recalibrating Its Commercialization Strategy With This Board Appointment?MarketBeat167d agoneutral
Ionis Pharmaceuticals Eyes Big Year With TRYNGOLZA Decision, 5 Phase 3 ReadoutsSimply Wall St.170d agobearish
Biogen Faces Trial Setbacks And Probes That Reframe Neuro Pipeline RisksStocktwits171d agobearish
BIIB, DNLI Stocks Edge Lower After Hours: Parkinson’s Drug Misses Key Goals In TrialSimply Wall St.174d agoneutral
How The Alector (ALEC) Investment Story Is Shifting With Tau Readthroughs And BBB Shuttle Focus